Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Making Science GroupFRA:MS7 67 Debt-to-EBITDA is -44.22 as of Dec. 2025. GuruFocus rates FRA:MS7 with a GF Score™ of 67/100 and a GF Value™ of €12.04 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 678 Media - Diversified companies, Making Science Group ranks worse than 84.81% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Making Science Group's Debt-to-EBITDA or its related term are showing as below:
FRA:MS7'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.07 Med: 7.89 Max: 22.9
Current: 7.89
During the past 7 years, the highest Debt-to-EBITDA Ratio of Making Science Group was 22.90. The lowest was 4.07. And the median was 7.89.
FRA:MS7's Debt-to-EBITDA is ranked worse than 84.81% of 678
companies
in the Media - Diversified industry
Industry Median: 1.655
vs FRA:MS7: 7.89
Making Science Group (FRA:MS7) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Making Science Group Debt-to-EBITDA Related Terms
Making Science Group Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Making Science Group's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MS7 vs APP, OMC, TTD: Debt-to-EBITDA Comparison
For the Advertising Agencies subindustry, Making Science Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Making Science Group Debt-to-EBITDA vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Making Science Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Making Science Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Making Science Group (FRA:MS7) has a Debt-to-EBITDA of -44.22 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Making Science Group. Over the past decade, Making Science Group's Debt-to-EBITDA has ranged from 4.07 to 22.90. According to the industry distribution chart, Making Science Group ranks #575 out of 678 companies in the Media - Diversified industry, placing it in the top 84.8%.
Is Making Science Group's Debt-to-EBITDA too high?
Making Science Group's current Debt-to-EBITDA is -44.22. Over the past 10 years, this metric has ranged from a low of 4.07 to a high of 22.90. Based on the distribution chart, Making Science Group ranks #575 out of 678 companies in the Media - Diversified industry, which is in the bottom quartile relative to peers. Overall, Making Science Group has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Making Science Group's Debt-to-EBITDA compare to APP and OMC?
According to the Media - Diversified industry distribution chart, Making Science Group ranks #575 out of 678 companies for Debt-to-EBITDA. This places Making Science Group in the lower half of its industry. The industry median Debt-to-EBITDA is 1.66. Historically, Making Science Group's own Debt-to-EBITDA has ranged from 4.07 to 22.90 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Media - Diversified company?
The median Debt-to-EBITDA among Media - Diversified companies is 1.66, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Making Science Group. For the Media - Diversified industry, the median Debt-to-EBITDA is 1.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Making Science Group's current Debt-to-EBITDA is -44.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Making Science Group stock overvalued right now?
Based on GuruFocus' analysis, Making Science Group (FRA:MS7) is currently considered Significantly Undervalued. The stock's GF Value™ is €12.04, compared to a current price of €6.45 — trading 46.4% below its estimated fair value. The current Debt-to-EBITDA is -44.22. Making Science Group's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Making Science Group (FRA:MS7), the current Debt-to-EBITDA is -44.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Making Science Group (FRA:MS7) Overvalued in 2026?
Based on GuruFocus' analysis, Making Science Group stock appears to be undervalued.
The current stock price of €6.45 is trading 46.4% below its estimated GF Value™ of €12.04.
GuruFocus considers Making Science Group to be Significantly Undervalued.
Key valuation signals for FRA:MS7:
Debt-to-EBITDA: -44.22
GF Value™: €12.04 vs. price of €6.45 (46.4% below fair value)
No single metric tells the full story. See the FRA:MS7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Making Science Group SA is engaged in the business of technology and marketing solutions for the e-commerce and digital transformation business. The company provides solutions in the areas of digital marketing, data analytics, e-commerce, and cloud. The company carries out its professional activity in the United States, Spain, Italy, France, and other. The company obtains its income mainly from advertising and public relations services. The business segments are: Spain; International; and E-commerce and Product. The Spain and International segments, the business lines are Media and Digital Marketing, Cloud Solutions, Software & Cybersecurity, and proprietary Adtech technology. The E-commerce and Product segment focuses on the Marketplace and E-commerce business lines.
67GF Score
Get the complete analysis for FRA:MS7
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MS7 has been successfully added to your 
